Literature DB >> 5166613

Blood coagulation initiation by a complement-mediated pathway.

T S Zimmerman, H J Müller-Eberhard.   

Abstract

A variety of complement-activating substances, including inulin, immunoglobulin aggregates, bacterial endotoxins, and staphylococcal protein A, were found to initiate blood coagulation through a complement-mediated pathway. These substances markedly accelerated blood coagulation in normal rabbit blood. That this clot-promoting activity requires an intact complement system was demonstrated by an almost total lack of effect on blood from rabbits with an inherited deficiency of the sixth component of complement (C6). Small amounts of isolated C6 conferred to C6-deficient blood the ability to respond with accelerated coagulation upon activation of the complement system. In addition, it was determined that activation of complement through the previously described C3 activator system resulted in the initiation of blood coagulation. The participation of C1, C2, and C4 was not necessary.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5166613      PMCID: PMC2139102          DOI: 10.1084/jem.134.6.1601

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  14 in total

1.  An immunofluorescent study of pathogenic mechanisms in glomerular diseases.

Authors:  R T McCluskey; P Vassalli; G Gallo; D S Baldwin
Journal:  N Engl J Med       Date:  1966-03-31       Impact factor: 91.245

Review 2.  F. The relation of complement to other systems.

Authors:  E L Becker
Journal:  Proc R Soc Lond B Biol Sci       Date:  1969-07-01

Review 3.  Some relationships among hemostasis, fibrinolytic phenomena, immunity, and the inflammatory response.

Authors:  O D Ratnoff
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

4.  The biologic activities of guinea pig antibodies. II. Modes of complement interaction with gamma 1 and gamma 2-immunoglobulins.

Authors:  A L Sandberg; A G Osler; H S Shin; B Oliveira
Journal:  J Immunol       Date:  1970-02       Impact factor: 5.422

5.  The biologic activities of guinea pig antibodies. I. Separation of gamma1 and gamma2 immunoglobulins and their participation in allergic reactions of the immediate type.

Authors:  B Oliveira; A G Osler; R P Siraganian; A L Sandberg
Journal:  J Immunol       Date:  1970-02       Impact factor: 5.422

6.  Activation of Hageman factor by ellagic acid and the generalized Shwartzman reaction.

Authors:  D G McKay; G Müller-Berghaus; V Cruse
Journal:  Am J Pathol       Date:  1969-03       Impact factor: 4.307

7.  Immunofluorescent localization of immunoglobulins, complement, and fibrinogen in human diseases. I. Systemic lupus erythematosus.

Authors:  F Paronetto; D Koffler
Journal:  J Clin Invest       Date:  1965-10       Impact factor: 14.808

8.  Endotoxin-induced kinin (bradykinin) formation: activation of Hageman factor and plasma kallikrein in human plasma.

Authors:  W A Pettinger; R Young
Journal:  Life Sci       Date:  1970-03-15       Impact factor: 5.037

9.  In vivo studies in C4-deficient guinea pigs.

Authors:  L Ellman; I Green; F Judge; M M Frank
Journal:  J Exp Med       Date:  1971-07-01       Impact factor: 14.307

10.  Interactions of the complement system with endotoxic lipopolysaccharide: consumption of each of the six terminal complement components.

Authors:  H Gewurz; H S Shin; S E Mergenhagen
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

View more
  29 in total

1.  Effects of intravascular clotting on the activation of the complement system: The role of the platelet.

Authors:  S Kalowski; E L Howes; W Margaretten; D G McKay
Journal:  Am J Pathol       Date:  1975-03       Impact factor: 4.307

2.  Effect of pneumococci on blood clotting, platelets, and polymorphonuclear leukocytes.

Authors:  J C Guckian
Journal:  Infect Immun       Date:  1975-10       Impact factor: 3.441

3.  Immunopathology of bullous pemphigoid. Basement membrane deposition of IgE, alternate pathway components and fibrin.

Authors:  T T Provost; T B Tomasi
Journal:  Clin Exp Immunol       Date:  1974-10       Impact factor: 4.330

4.  Complement activation in children with acute malaria.

Authors:  B M Greenwood; M J Brueton
Journal:  Clin Exp Immunol       Date:  1974-10       Impact factor: 4.330

5.  Analysis of bypass activation of C3 by endotoxic LPS and loss of this potency.

Authors:  M P Dierich; D Bitter-Suermann; W König; U Hadding; C Galanos; E T Rietschel
Journal:  Immunology       Date:  1973-04       Impact factor: 7.397

6.  The role of complement in localized shwartzman reaction: studies with congenitally C6-deficient rabbits.

Authors:  J S Fong; K O Rother; R A Good
Journal:  Clin Exp Immunol       Date:  1974-01       Impact factor: 4.330

7.  Maturation of the human complement system. I. Onset time and sites of fetal C1q, C4, C3, and C5 synthesis.

Authors:  P F Kohler
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

8.  The platelet as an inflammatory cell.

Authors:  R L Nachman; M Polley
Journal:  Trans Am Clin Climatol Assoc       Date:  1979

9.  Abnormal platelet function in C3-deficient mice.

Authors:  F C Gushiken; H Han; J Li; R E Rumbaut; V Afshar-Kharghan
Journal:  J Thromb Haemost       Date:  2009-03-05       Impact factor: 5.824

10.  Interactions of the classical and alternate complement pathway with endotoxin lipopolysaccharide. Effect on platelets and blood coagulation.

Authors:  M A Kane; J E May; M M Frank
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.